Targeted Metabolomic Profiling of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The PRESERVED-HF Trial.
Selvaraj S, Patel S, Sauer AJ, McGarrah RW, Jones P, Kwee LC, Windsor SL, Ilkayeva O, Muehlbauer MJ, Newgard CB, Borlaug BA, Kitzman DW, Shah SJ, Shah SH, Kosiborod MN; PRESERVED-HF Investigators.
Selvaraj S, et al. Among authors: patel s.
JACC Heart Fail. 2024 Apr 3:S2213-1779(24)00182-3. doi: 10.1016/j.jchf.2024.02.018. Online ahead of print.
JACC Heart Fail. 2024.
PMID: 38639697